This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Washington. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Qingxin Mu: Innovator in Targeted Chemo-Immunotherapy
Introduction
Qingxin Mu is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of targeted cancer therapies through his innovative research and development of multifunctional nanoparticles.
Latest Patents
Qingxin Mu holds a patent for an "Iron oxide nanoparticle for targeted chemo-immunotherapy." This multifunctional nanoparticle is designed for targeted therapeutic drug delivery and comprises several key components. It features an iron oxide core with silica-polyethylene glycol coupled to provide an iron oxide coated core. Additionally, it includes a cytotoxic agent and an immunomodulating agent that are reversibly associated with the coated core, along with a tumor-targeting agent. The patent outlines methods for using the nanoparticle to treat cancers and methods for its production.
Career Highlights
Qingxin Mu is affiliated with the University of Washington, where he continues to advance his research in nanotechnology and cancer treatment. His work has garnered attention for its potential to improve therapeutic outcomes for cancer patients.
Collaborations
Qingxin Mu collaborates with notable colleagues, including Miqin Zhang and Guanyou Lin, who contribute to his research endeavors and enhance the impact of his innovations.
Conclusion
Qingxin Mu's work in developing targeted chemo-immunotherapy nanoparticles represents a significant advancement in cancer treatment. His innovative approach has the potential to transform therapeutic strategies and improve patient outcomes.